Best NSAID for Mild Shoulder Osteoarthritis
For mild shoulder osteoarthritis, start with topical NSAIDs as the first-line NSAID therapy before considering oral agents, and if oral NSAIDs are needed, choose either naproxen (for patients with cardiovascular risk factors) or low-dose celecoxib 200 mg/day, always co-prescribed with a proton pump inhibitor.
Treatment Algorithm
Step 1: Non-Pharmacological Foundation
Before any NSAID, ensure the patient is engaged in:
- Regular strengthening exercises for the shoulder
- General aerobic fitness training
- Weight loss if BMI >25 1
Step 2: First-Line Pharmacological Treatment
Start with paracetamol (acetaminophen) up to 4 grams daily with regular dosing 1. This remains the safest initial option despite limited efficacy data specifically for shoulder OA.
Step 3: NSAID Selection When Paracetamol Fails
For Shoulder-Specific Considerations:
Topical NSAIDs should be tried first 1. While guideline evidence specifically mentions knee and hand OA, the shoulder joint is accessible for topical application and carries minimal systemic risk.
If Oral NSAIDs Are Required:
Choice depends on patient risk profile:
For patients WITHOUT significant cardiovascular risk:
- Diclofenac 150 mg/day has the strongest evidence for efficacy (effect size -0.57) 2
- Alternative: Etoricoxib 60 mg/day (effect size -0.58) 2
For patients WITH cardiovascular risk factors:
- Naproxen is preferred due to neutral cardiovascular risk profile 3, 4, 5
- Low-dose celecoxib 200 mg/day is an acceptable alternative with lower CV risk than other coxibs 3, 5
For patients WITH gastrointestinal risk factors:
- COX-2 inhibitors (celecoxib) have superior GI safety 6, 7
- Always co-prescribe a proton pump inhibitor regardless of NSAID choice 1
Critical Prescribing Principles
Dosing strategy: Use the lowest effective dose for the shortest duration 1. All oral NSAIDs have similar analgesic magnitude but differ substantially in toxicity profiles 1.
Mandatory co-prescription: A proton pump inhibitor should accompany any oral NSAID or COX-2 inhibitor, selecting the lowest acquisition cost option 1.
Risk assessment required: Before prescribing, evaluate:
- Age (elderly at higher risk)
- Cardiovascular disease or risk factors
- History of GI ulcers or bleeding
- Renal function
- Concurrent aspirin use 1
Important Caveats
Aspirin interaction: If the patient takes low-dose aspirin, consider other analgesics first. If NSAIDs are necessary, avoid ibuprofen as it attenuates aspirin's antiplatelet effects 4. Naproxen does not interfere with aspirin 4.
Etoricoxib 60 mg exception: Guidelines specifically exclude etoricoxib 60 mg as a first-choice COX-2 inhibitor 1, though the rationale relates to cost-effectiveness rather than safety.
Duration matters: NSAIDs work best during periods of active inflammatory pain 8. For mild OA, consider as-needed dosing rather than continuous therapy 9.
Monitoring: While only 13.4% of rheumatologists routinely check renal function before NSAID initiation 9, this represents a gap in practice—baseline assessment is prudent, especially in elderly patients.
Evidence Strength
The NICE guidelines 1 provide the framework, though they focus primarily on knee and hand OA. The 2017 Lancet network meta-analysis 2 provides the highest-quality comparative efficacy data, demonstrating diclofenac 150 mg/day and etoricoxib 60 mg/day as most effective. However, safety considerations must override pure efficacy when selecting NSAIDs, particularly given the cardiovascular concerns with diclofenac 3, 4.
The ACR 2019 guidelines 10 made strong recommendations for topical NSAIDs specifically for knee OA, and this principle reasonably extends to the accessible shoulder joint.